Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergyRS Negrin, PL Greenberg, R S Stein et al.|Blood|1996Cited by 209
Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cellsRanjani Rajapaksa, PL Greenberg, L S Rott et al.|Blood|1996Cited by 193
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin [see comments]RS Negrin, PL Greenberg, Susan E. Krantz et al.|Blood|1993Cited by 155
The smoldering myeloid leukemic states: clinical and biologic featuresPL Greenberg|Blood|1983Cited by 144
In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.PL Greenberg|PubMed|1986Cited by 64